Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.

Should Depressive Syndromes Be Reclassified as “Metabolic Syndrome Type II”?

Abstract

Background A nascent explanatory theory regarding the pathophysiology of major depressive disorder posits that alterations in metabolic networks (e.g., insulin and glucocorticoid signaling) mediate allostasis. Method We conducted a PubMed search of all English-language articles published between January 1966 and September 2006. The search terms were: neurobiology, cognition, neuroprotection, inflammation, oxidative stress, glucocorticoids, metabolic syndrome, diabetes mellitus, insulin, and antidiabetic agents, cross-referenced with the individual names of DSM-III-R/IV/-TR-defined mood disorders. The search was augmented with a manual review of article reference lists; articles selected for review were determined by author consensus. Results Disturbances in metabolic networks: e.g., insulin-glucose homeostasis, immuno-inflammatory processes, adipokine synthesis and secretion, intra-cellular signaling cascades, and mitochondrial respiration are implicated in the pathophysiology, brain volumetric changes, symptomatic expression (e.g., neurocognitive decline), and medical comorbidity in depressive disorders. The central nervous system, like the pancreas, is a critical modulator of the metabolic milieu and is endangered by chronic abnormalities in metabolic processes. We propose the notion of "metabolic syndrome type II" as a neuropsychiatric syndrome in which alterations in metabolic networks are a defining pathophysiological component. Conclusion A comprehensive management appr…

Overview

Integrity signals

Registry

Crossref · 10.1080/10401230701653377

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 80 references

Cited by

See all 283

Metadata

Authors
McIntyre, R. S., Soczynska, J. K., Konarski, J. Z., Woldeyohannes, H. O., Law, C. W. Y., Miranda, A., Fulgosi, D., & Kennedy, S. H.
Affiliations
University Health Network (CA)
Venue
Annals of Clinical Psychiatry
Published
2007-10
Volume
19
Issue
4
Pages
257-264
ISSN
  • 1040-1237 (ISSN-L)
  • 1547-3325
OpenAlex
W1986031990
Cited by
277
References
80
Citations by year
2026: 6 · 2025: 18 · 2024: 12 · 2023: 7 · 2022: 10 · 2021: 13 · 2020: 10 · 2019: 8 · 2018: 12 · 2017: 14 · 2016: 21 · 2015: 19 · 2014: 17 · 2013: 15 · 2012: 16
FWCI
10.86
Type
journal article
Language
en
Open access
closed
Locations
  • Annals of Clinical Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
major depressive disorder, metabolic networks, insulin signaling, glucocorticoid signaling, allostasis, neuroinflammation, adipokines, oxidative stress, mitochondrial respiration, neurocognitive decline, cardiovascular comorbidity, disease-modifying therapy, mood disorders
MeSH terms
Aged, Bipolar Disorder, Brain, Depressive Disorder, Diagnosis, Differential, Female, Glucocorticoids, Humans, Insulin, Magnetic Resonance Imaging, Male, Signal Transduction, Oxidative Stress, Metabolic Syndrome, Diagnostic and Statistical Manual of Mental Disorders, Positron-Emission Tomography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Should Depressive Syndromes Be Reclassified as “Metabolic Syndrome Type II”? https://app.cochat.ai/papers/10.1080/10401230701653377
The paper
McIntyre, R. S., Soczynska, J. K., Konarski, J. Z., Woldeyohannes, H. O., Law, C. W. Y., Miranda, A., Fulgosi, D., & Kennedy, S. H. (2007). Should Depressive Syndromes Be Reclassified as “Metabolic Syndrome Type II”? Annals of Clinical Psychiatry. https://doi.org/10.1080/10401230701653377

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.